Udg Healthcare (LON:UDG) Stock Rating Reaffirmed by Liberum Capital
Liberum Capital restated their buy rating on shares of Udg Healthcare (LON:UDG) in a research note issued to investors on Wednesday, ThisIsMoney.Co.Uk reports.
UDG has been the topic of several other research reports. Peel Hunt reissued a buy rating on shares of Udg Healthcare in a report on Thursday, March 5th. Berenberg Bank raised Udg Healthcare to a buy rating and boosted their target price for the stock from GBX 850 ($11.18) to GBX 920 ($12.10) in a report on Monday, January 20th. Barclays boosted their target price on Udg Healthcare from GBX 830 ($10.92) to GBX 910 ($11.97) and gave the stock an overweight rating in a report on Tuesday, January 21st. Finally, Jefferies Financial Group boosted their target price on Udg Healthcare from GBX 620 ($8.16) to GBX 735 ($9.67) and gave the stock a hold rating in a report on Tuesday, January 21st. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Udg Healthcare presently has a consensus rating of Buy and an average target price of GBX 892 ($11.73).
LON:UDG traded up GBX 43.50 ($0.57) during midday trading on Wednesday, hitting GBX 577.50 ($7.60). 1,295,635 shares of the stock were exchanged, compared to its average volume of 981,360. Udg Healthcare has a one year low of GBX 545 ($7.17) and a one year high of GBX 846 ($11.13). The company has a market capitalization of $1.45 billion and a price-to-earnings ratio of 25.22. The business has a 50-day moving average price of GBX 710.67 and a two-hundred day moving average price of GBX 762.88. The company has a current ratio of 1.59, a quick ratio of 1.43 and a debt-to-equity ratio of 26.65.
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.
Further Reading: Inverted Yield Curve
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.